Insider
Doximity, Inc.DOCS

Doximity rolls out AI tools at major medical systems

NewYork-Presbyterian, Columbia University and Weill Cornell Medicine began deploying Doximity's Doximity Ask and Doximity Scribe artificial intelligence tools within their Epic electronic health record systems. This integration expands clinician capabilities for decision-making and medical documentation across these large academic institutions.

Verified against 3 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
Doctor examining mri scans on a tablet screen
Photo by Vitaly Gariev on Unsplash
10,721
Shares sold
$375,235
Value of shares sold
2,523 shares
Proposed sale

Key points

  • Doximity announced the deployment of its specialized AI tools at three major medical systems.
  • This new AI rollout builds on Doximity's ongoing collaboration with NewYork-Presbyterian, dating back to 2021.
  • Director Timothy S. Cabral converted derivative securities and sold 10,721 shares on November 5, 2026, under a Rule 10b5-1 trading plan—a preset selling schedule executives set up in advance—for $375,235.

Integrating clinical AI into medical systems

Doximity announced the deployment of its specialized AI tools at three major medical systems. Doximity Ask provides clinical decision support based on peer-reviewed medical literature, clinical guidelines and physician peer reviews, while Scribe assists with documentation automation, including dictation and drafting notes during patient visits.

Expanding collaboration with medical institutions

This new AI rollout builds on Doximity's ongoing collaboration with NewYork-Presbyterian, dating back to 2021. Previous interaction with the facility focused on using the Dialer tool for audio and video consultations.

Company insider transactions

Director Timothy S. Cabral converted derivative securities and sold 10,721 shares on November 5, 2026, under a Rule 10b5-1 trading plan—a preset selling schedule executives set up in advance—for $375,235.

Additionally, on November 16, 2026, officer Siddharth Sitaram filed a Form 144 notice of a proposed sale for 2,523 shares obtained through a stock option exercise. The plan governing this transaction was adopted on February 27, 2026.

Information limitations

Financial terms of the agreements with NewYork-Presbyterian, Columbia University and Weill Cornell Medicine were not publicly disclosed. It is also unclear what proportion of clinicians at these medical facilities will use the new AI tools in daily practice.

What shareholders should monitor

Shareholders should monitor the number of additional major medical systems adopting Doximity's AI toolset. Data on the scale and adoption pace of this technology is expected in future press releases and quarterly financial reports.

Original sources

  1. NewYork-Presbyterian, Columbia and Weill Cornell Medicine Bring Doximity's Clinical AI Into EpicNovember 13, 2026SHA-256 of our archived copy fb66fe6d82fa…
  2. 4 filing, November 9, 2026November 9, 2026SHA-256 of our archived copy 7aa3849fe7af…
  3. 144 filing, November 16, 2026November 16, 2026SHA-256 of our archived copy 4530202748a4…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards